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Abstract
The study examined results from previous studies of early life vitamin D exposure and risk of
MS in adulthood, including studies on season or month of birth and of migration. A system-
atic review was conducted using PubMed and Web of Science databases as well as check-
ing references cited in articles. The quality of studies was assessed using the Newcastle-
Ottawa scale and the AMSTAR score. Twenty-eight studies were selected for analysis. Of
these, six population studies investigated early life vitamin D exposure and risk of MS, and
three found inverse while the remaining found no associations. A consistent seasonal ten-
dency for MS seemed evident from 11/15 studies, finding a reduced occurrence of MS for
Northern hemisphere children who were born late autumn, and late fall for children born in
the Southern hemisphere. This was also confirmed by pooled analysis of 6/15 studies.
Results of the migration studies showed an increased risk of MS if migration from high to
low-MS-risk areas had occurred after age 15 years, while risk of MS was reduced for those
migrating earlier in life (<15years). A similar, but inverse risk pattern was observed among
migrants from low to high-MS-risk areas. One study found an increased risk of MS in the
second generation of migrants when migrating from low to high-MS-risk areas. An associa-
tion between early life vitamin D and later risk of MS seems possible, however evidence is
still insufficient to conclude that low vitamin D exposure in early life increases the risk of MS
in adulthood.
PROSPERO register number: CRD 42016043229.
Introduction
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease that affects the Central
Nervous System (CNS). It is one of the most common neurological disorders occurring in
young and middle-aged adults and is more common in women than men [1,2]. It is affecting
more than 2.1 million people worldwide and its prevalence is increasing [1]. Even though
some patients with MS may experience a light form of disability only, more than 60% of those
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with MS are no longer capable of working. In most cases, the disease decreases the quality of
patients’s life and causes a considerable health and economic burden to society [3]. It is, there-
fore, vital to search for aetiological factors for MS and to identify cost-effective preventive
strategies to reduce the burden of disease.
The aetiology of MS is currently unknown although assumed to be caused by a combination
of genetic and environmental factors [4]. However, the uneven geographic distribution of the
MS is apparent from epidemiological studies where increased rates are seen in high-latitude
regions, while MS is uncommon close to the equator, leading to north-south prevalence gradi-
ent [5]. The MS distribution was categorized by Kurtzke et al. [6] according to MS prevalence
rates in three geographical zones: high, medium and low prevalence areas. This unequal distri-
bution is expected to be amongst others due to higher vitamin D levels via sun exposure in
warmer climates (low risk regions), while lower in cooler climates (high risk regions).
An increasing body of evidence suggests that the disease may be associated with exposure
to the Epstein-Barr virus, smoking and high body mass index in childhood and adolescence
[7–10]. Moreover, in recent years, vitamin D insufficiency has been suggested as potential pre-
disposing factors for development of MS [1,11,12]. In this regard, it has been hypothesized
that a higher availability of vitamin D may reduce the immune system’s inflammatory response
and hence reduce the risk of autoimmune disorders leading to MS [13]. Furthermore, recent
research suggests that low vitamin D occurring during sensitive stages of development, such
pre- and perinatal life may be a particular concern in relation to later risk of MS [14]. Experi-
ments on rats, using developmental vitamin D deficiency models, have shown alterations in
the brain of offspring from vitamin D deficient compared to vitamin D sufficient rat mothers,
including a reduced cell differentiation, and expression of neurotrophic factors, effects that
may persist into adulthood [15]. However, results from studies on experimental autoimmune
encephalomyelitis from animal models, on the role of vitamin D during early development are
limited and inconsistent [16]. So far, results from human studies that examined the influence
of human vitamin D availability in early life (pre- and perinatal period) on the risk of MS in
adulthood have not been comprehensively summarized, and we therefore conducted a system-
atic literature review of the results from available intervention and population studies. As sea-
son, latitude and migration relates to sun and UVB exposure, and may provide correlational
type of evidence relating early life vitamin D exposure to MS, this review also includes a meta-
analysis of pooled results from season or month of birth, and an update of studies examining
latitudinal gradients and age and generation at migration studies in relation to later MS
occurrence.
Methods
Protocol and registration
Search methods have been explicitly defined in advance in order to reduce researcher bias
(PROSPERO 2016: CRD 42016043229).
Search methods and terms used
The literature search was performed through the PubMed/Medline platform in July 2018.
Additionally, Web of Science was used to identify articles cited in included publications after
having checked the reference list of retrieved papers. The terms used for the article search
combined key terms for vitamin D, month or season of birth, migration and multiple sclerosis
(for further details, see S1 Table). The search using the same search strategy was updated
before the final analysis to retrieve further studies for inclusion.
Early life vitamin D and multiple sclerosis
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Abbreviations: 25(OH)D, 25-hydroxyvitamin D;
CNS, Central Nervous System; ICD, International
Classification of Diseases; MS, Multiple Sclerosis.
Selection criteria
Two independent researchers performed the selection of papers and examined titles and
abstracts to exclude studies that did not meet predefined inclusion criteria. Then, full papers
were screened and selected for this review. In case of uncertainty, a third researcher was
involved. The PRISMA Statement was used as a guideline [17].
Eligibility criteria for inclusion in this review
Predefined inclusion criteria stated that studies must:
i) Investigate the association between early life vitamin D and the risk of developing MS in
adulthood. The review limited itself to the pre- (the time between conception and birth) and
perinatal period (from birth to 1 month); ii) Assess the season or month of birth as risk factor
for development of MS; iii) Examine the difference in risk of MS between early and late
migrants or between the first and the second generation of migrants. The region where the
studies were conducted is important in order to understand possible relationships between the
season or the month-of-birth effects on MS susceptibility for different latitudinal gradients
[18]. Therefore, there was no limitation on study location.
Types of studies
To be included in this review articles had to adhere to one of the following study designs: (i)
intervention studies, (ii) cohort studies, case-control studies; nested case-control studies, case-
cohort studies, or cross-sectional studies; (iii) systematic reviews.
Characteristics of participants
To be included in this review, publications were included only if they comprised participants
that met the following criteria: (i) for vitamin D analysis: pregnant women without MS and
neonates (from birth to 1 month); (ii) for season/month of birth and migration analysis: adult
patients with MS (diagnosed by any criterion) and affected by any type of MS such as relapsing
remitting, secondary progressive, primary progressive, progressive relapsing.
Types of interventions/exposures
Studies were selected for inclusion based on the following types of exposures: (i): vitamin D
(ii) season/month of birth; (iii) migration (age at migration, changes in latitude regions, and
the risk difference between generations of migrants).
Types of outcome measures
The outcome of interest was: diagnosis of MS / adults patients with MS
Exclusion criteria
The following types of publications were not included: (i) papers not published in English; (ii)
case reports, case series, study protocols, opinion documentations, letters, editorials or com-
mentaries, dissertations, book reviews, common (non-systematic) reviews and animal studies.
Data extraction and quality assessment
On each included publication, information was extracted and tables created with information
on the author, year of publication, study objectives, design, setting, sample size, age, and gen-
der of MS patients, exposure, main findings and methodological quality. For the season or
Early life vitamin D and multiple sclerosis
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month of birth analysis, additional data was extracted on estimated latitude of country. If the
original paper did not include this information Google map was used to determine an esti-
mated mean latitude of the country. At the level of the systematic review, data was extracted
on author name, year of publication, number of included studies, methodological quality and
main findings, while for migration studies data was extracted on author and year, country of
origin, country of migration, main findings and methodological quality. At the level of meta-
analysis, numbers of observed and expected births of MS patients for each month and risk esti-
mates were extracted.
The quality of included studies was assessed using the Newcastle-Ottawa scale for observa-
tional studies, and the Assessment of Multiple Systematic Reviews (AMSTAR) score for sys-
tematic reviews [19]. A quality score for observational studies was calculated based on three
major components of the Newcastle-Ottawa scale: (1) selection of the groups included to the
study, (2) comparability, (3) assessment of the outcome or exposure. The maximum score
was 9 points, representing the highest methodological quality, while a quality score of system-
atic reviews was categorized as low (0–3), moderate (4–7) or high (8–11) according to the
AMSTAR score instructions (for further details, see S3 File).
Statistical analysis
Month of birth and risk of MS. In total 6/15 studies provided full statistical information
on month of birth and subsequent MS risk and were included for this meta-analysis. From
each study we extracted the observed and expected number of MS in each month. The
expected number represent the expected number of MS if there were no seasonal variation by
month. Standardized incidence ratios (SIR) were calculated as the ratio between observed and
expected MS. The standard error of log (SIR) was calculated as 1 divided by the square root of
the observed number O of MS, hence the expected number is treated as a known background
incidence of MS in the population. The SIR’s were combined using separate random-effects
meta-analyses. Heterogeneity between studies was assessed by the I2 statistics [20]. The analy-
sis was carried out in R version 3.5.1 [21] using the Meta package [22].
Results
Study selection
Based on the search strategy, a total of 267 citations (259 from PubMed/Medline and an addi-
tional 8 from citation searches and reference lists) were identified. After reviewing the title
and/or abstract of all the citations and removing duplicates, 192 citations were excluded as
they did not meet the inclusion criteria. For the remaining 67 studies, the full text was
retrieved. In order to avoid duplications only studies with original results were included. Fur-
thermore, for the correlation type studies we only included studies that had not been included
in two previously published systematic reviews of season or month of birth, and latitudinal
gradients and age and generation at migration studies. The same search strategy was per-
formed in July 2018. This revealed additionally three studies. A final number of 28 articles thus
met the inclusion criteria. The number of included and excluded articles with reasons for
exclusion is shown in (Fig 1).
Study characteristics
No published intervention studies, but six observational population studies, seventeen season
of birth studies and five migration studies were identified (Fig 1). Tables 1–4 feature the char-
acteristics, main findings and quality of the 28 included studies. The studies were highly
Early life vitamin D and multiple sclerosis
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diverse with respect to design, methods, and participants included. Therefore, a meta-analysis
of the results of the included studies could not be performed for all studies. Due to this hetero-
geneity, the analysis of study types is done separately. However, it was possible to pool the
results of 6/15 seasonal studies.
Population studies. Four case-cohort studies examined levels of 25(OH)D from maternal
or neonatal blood [23–26], while a fifth case-control study asked cases about cod liver oil sup-
plementation in early childhood [27]. Finally, one [28] population study related maternal milk
intake, maternal dietary vitamin D intake and predicted maternal serum to the subsequent off-
spring risk of MS in adulthood (Table 1). Overall, of the six population studies, three demon-
strated significant inverse [25,26,28], and the remaining three studies no associations between
early vitamin D exposure and later risk of MS [23,24,27]. Five of the studies were from Nordic
countries and one [28] was from the US. Studies were published between 2011 and 2016. The
number of cases in the studies ranged from 37 to 953. The mean age of MS patients at the
onset of disease ranged from 19 to 37 years.
The US study investigated gestational vitamin D availability by predicted rather than mea-
sured maternal 25(OH)D concentrations and by self-reported dietary vitamin D intake during
the entire pregnancy [28], while except for one study, the remaining studies used measured
neonatal or maternal 25(OH)D concentrations during early pregnancy. Of these studies, four
were rated as very good and one as “only” good quality The final study that asked cases about
cod liver oil supplementation in early childhood [27], gained the lowest quality among the six
studies, both because exposure was assessed over a quite a long age range (ages 0–12), rather
than being restricted to pre- or perinatal life, and because of the use of self-administered ques-
tionnaires in the ascertainment of exposure, which may have caused recall bias and impacted
the validity of the study findings.
Fig 1. Flow chart with information on the identified and excluded studies.
https://doi.org/10.1371/journal.pone.0221645.g001
Early life vitamin D and multiple sclerosis
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Table 1. Characteristics of population studies investigating influence of vitamin D availability in early life and the risk of MS in adulthood.
First
author, y
(ref)
Objective Study design Study
setting
Exposure Median/
Mean age
at MS
onset
Gender
distribution of
cases n (%)
Population Main findings Quality
Female Male
Mirzaei
et al.
2011 [28]
To study the effect of
gestational vitamin D on
adult onset of MS
Cohort USA Dietary
vitamin D
Fortified milk
Predicted
serum 25(OH)
D
n.a Female nurses
35,372
n = 35,794
mothers of
participants,
n = 199 MS
cases
High maternal milk (RR
0.62, 95%CI 0.40–0.95),
vitamin D intake (RR
0.57, 95% CI 0.35–0.91)
and serum (25(OH)D)
level (RR 0.59, 95% CI
0.37–0.92) associated with
lower risk of developing
MS in offspring
8
Salzer
et al.
2012 [23]
To examine the
association between
25-hydroxyvitamin D
levels and the risk of MS
in blood samples collected
prospectively and during
gestation
Prospective
nested case
—control
Sweden 25(OH)D
levels during
early
pregnancy
Median
21 (13–
32)
27 (73) 10
(27)
n = 37 cases,
n = 185
controls
MS risk in offspring
exposed to low gestational
25(OH)D levels (<75
nmol/L vs. �75 nmol/L)
not different (OR 1.8,
95% CI 0.53–5.8)
6
Ueda
et al.
2014 [24]
To assess the relation
between neonatal vitamin
D concentration,
measured in stored blood
samples, and risk of MS
Population
based case—
control
Sweden 25(OH)D
levels in
newborns
Mean
25.1 [4.7]
349
(76)
110
(24)
n = 459 cases,
n = 663
controls
No association between
neonatal 25
-hydroxyvitamin D
quintile and risk of MS
(OR 1.0, 95% CI 0.68–
1.44)
8
Cortese
et al.
2015 [27]
To investigate the
association between
vitamin D3
supplementation at
different postnatal ages
and MS risk
Case—
control
Norway Cod liver oil
supplements
Mean
37.6
[10.2]
667
(70)
286
(30)
n = 953 cases,
n = 1,717
controls
Supplementation during
early childhood (0-12y)
did not influence MS risk
(OR 1.01, 95% CI 0.81–
1.26)
6
Munger
et al.
2016 [25]
To examine whether
serum 25-hydroxyvitamin
D levels in early pregnancy
are associated with risk of
MS in offspring
Prospective
nested case
—control
Finland Maternal
serum 25(OH)
D levels
Mean
19.8 [3.2]
163
(84)
30
(16)
n = 176 cases,
n = 326
controls
Maternal vitamin D
deficiency (25(OH)D
levels, 12.02 ng/ml)
during early pregnancy
was associated with
nearly two fold higher
risk of MS in the
offspring (RR 1.90, 95%
CI 1.20–3.01)
8
Nielsen
et al.
2017 [26]
To examine direct
association between level
of neonatal vitamin D and
risk of MS
Population
based case—
control
Denmark 25(OH)D
levels in
newborns
n.a 354
(68)
167
(32)
n = 521 cases,
n = 972
controls
In the quantile based
analysis, MS risk was
highest among
individuals in the lowest
quintile (<20.7nmol/L vs
�48.9 nmol/L) (OR 0.53,
95% CI 0.36–0.78). In the
analysis of 25(OH)D as a
continuous variable, a
25nmol/L increase
reduced the risk of MS by
30% (OR 0.70, 95% CI
0.57–0.84)
8
MS, multiple sclerosis; n.a, not available; RR, relative risk; CI, confidence interval; OR, odds ratio; [SD], standard deviation/(range).
https://doi.org/10.1371/journal.pone.0221645.t001
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All studies were controlled for sex and age, four of the studies performed further multivari-
ate adjusted analysis, although adjustment for relevant covariates such as ethnicity, latitude
and season of births did not substantially affect the results [24–26,28]. Due to the using of sub-
jective measures for exposure (e.g. dietary recall, predicted serum 25(OH)D levels) or inade-
quate representativeness of cases and/or lack of adjustments for important confounders none
of the studies reached maximum quality score. For instance, Mirzaei and colleagues [28]
assessed maternal serum 25(OH)D levels from non-pregnant women, and Munger and col-
leagues [25] had measures only from the first trimester of pregnancy; thus, variation in serum
25(OH)D levels in subsequent trimesters, related to likely variations in diet intake of pregnant
women over the pregnancy and according to season [29], cannot be excluded.
The season or the month of birth as risk factor for MS. Of the identified seventeen
studies, two were systematic reviews, one of which also comprised a meta-analysis [18,30]
(Table 2). Both reviews were rated of moderate quality (AMSTAR score 4–7) (Table C in S2
Table). The review by Torkildsen et al. [18] reported that most of the total of 17 included stud-
ies found a month-of-birth effect, and they concluded that in the Northern hemisphere the
birth month of future MS cases seemed to be more frequent in April and May and less frequent
in November and December, while a reverse but otherwise similar pattern was identified for
Table 2. Characteristics of systematic reviews investigating the season or month of birth as a risk factor for development of MS.
First author, y (ref) Study design No. of studies
included
Hemispheres Main findings Quality
Excess Reduced
Torkildsen et al. 2012
[18]
Systematic review 17 Northern
hemisphere
April-May November-
December
Moderate
Southern
hemisphere
November May
Dobson et al. 2013 [30] Systematic review and meta-
analysis
10 Northern
hemisphere
April1
(O:E 1.05, p = 0.05)
October1
(O:E 0.95, p = 0.04)
November
(O:E 0.92, p = 0.01)
Moderate
November2
(O:E 0.93, p = 0.04)
April3
(O:E 1.08,
p = 0.001)
May
(O:E 1.11,
p = 0.007)
June
(O:E 0.94, p = 0.05)
October3
(O:E 0.94, p = 0.006)
November
(O:E 0.89, p = 0.004)
April4
(O:E 1.08,
p = 0.004)
May
(O:E 1.09,
p = 0.002)
October4
(O:E 0.95, p = 0.03)
November
(O:E 0.90,p = 0.03)
Gale et al. 1995 [51]a Systematic review 28 Moderate
O:E, observed-expected ratio.
1All reported data analysis;
2Population-conservative analysis;
3Geographically-conservative analysis;
4Overall-conservative analysis.
aThis study reviewed migration studies (for the results refer to main text).
https://doi.org/10.1371/journal.pone.0221645.t002
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Table 3. Characteristics of studies assessing the season or month of birth as a risk factor for development of MS.
First
author, y
(ref)
Study setting Estimated
latitude
Population Gender
distribution of
cases n
Median/
Mean age at
MS onset
Statistic test Main findings Quality
Male Female Excess Reduced
Northern hemisphere
Gardener
et al. 2009
[38]
USA 37˚N n = 723 MS
patients
Female nurses
723
n.a RR (95%CI) Spring
(RR 1.13, 95%
CI, 0.88–1.46)
Summer
(RR1.05, 95%
CI, 0.70–1.59)
Fall
(RR 0.93, 95%
CI, 0.67–1.28)
Winter
(reference
category 1.0)
7
Streym et al.
2013 [42]
Denmark 55.7˚N n = 103 MS
patients
n.a n.a n.a HR (95% CI) April-
September
October-
March
(HR 0.70 95%
CI, 0.47–1.04,
p = 0.07)
7
Barros et al.
(2013) [32]
Portugal (Northwestern
region)
41.08˚–
41.7˚ N
n = 421 MS
patients,
n = population
control
128 293 44.55 X2 and Hewitt July-December
Hewitt
(p > 0.05)
n.s 7
Torkildsen
et al. 2014
[33]
Norway 62˚N n = 6,649 MS
patients,
n = population
control,
MS unaffected:
mothers
(n = 5,711),
fathers
(n = 5,247),
siblings
(n = 8,956)
n.a n.a n.a X2, Fishers
exact and
Bonferroni
April
(p = 0.007)
Bonferroni
(p = 0.09)
n.s 7
Akhtar et al.
2014 [34]
Kuwait 29.3˚N n = 237 MS
patients,
n = 997,269 non-
national births in
general
population
n.a n.a n.a X2 and Hewitt September-
February
Hewitt p = 0.09
n.s 5
Akhtar et al.
2015 [35]
n = 1,035 MS
patients,
n = population
control
358 677 n.a X2 and RR
(95%CI),
Cosinor
December
(RR 1.3, 95%
CI, 1.1–1.6,
p = 0.003)
Cosinor
p = 0.007
May
(RR 0.76, 95%
CI, 0.60–0.95,
p = 0.015)
5
Tolou-
Ghamari
et al. 2015
[40]
Isfahan, Iran 32.6˚N n = 1,283 MS
patients
304 979 34.6 Descriptive
statistics
April, May,
September
November 3
Poorolajal
et al. 2015
[41]
Hamadan, Iran 34.7˚N n = 100 MS
patients,
n = 100 control
group with acute
infectious disease
20 79 36.1 OR (95%CI) Autumn
(September,
October,
November)
(OR 2.77, 95%
CI, 1.22–6.30)
Spring
(reference
category 1.00)
5
Sidhom et al.
2015 [36]
Tunisia 33.8˚N n = 1,912 MS
patients,
n = population
control
545 1,187 n.a X2 and Hewitt May-October November-
April
6
X2- n.s
Hewitt (p = 0.03)
(Continued)
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PLOS ONE | https://doi.org/10.1371/journal.pone.0221645 August 27, 2019 8 / 18
the Southern hemisphere. As mentioned above, almost all studies were from the Northern
hemisphere (16/17), and all except three (3/17) found associations between month of birth and
MS.
The review by Dobson et al. [30] included a meta-analysis and was based on a total of 10
studies published after the year 2000. The meta-analysis found that fewer MS cases than
expected occurred in subjects born in October and November, while more than expected MS
cases were born in April in the Northern hemisphere. The review performed three types of
Table 3. (Continued)
First
author, y
(ref)
Study setting Estimated
latitude
Population Gender
distribution of
cases n
Median/
Mean age at
MS onset
Statistic test Main findings Quality
Male Female Excess Reduced
Rodriguez
Cruz et al.
2016 [45]
United Kingdom 53.1˚N n = 6,372 MS
patients,
(regional MS
Cohort)
n.a n.a n.a OR (95%CI)
and Walter
and Elwood
test
April
(Obs/Exp 1.24,
95CI%, 1.10–
1.41)
November
(Obs/Exp
0.84, 95%CI,
0.76–0.92)
6
n = 21,138 MS
patients
n = population
control
April
(Obs/Exp 1.07,
95%CI, 1.02–
1.11)
November
(Obs/Exp
0.91, 95%CI,
0.87–0.95)
Balbuena
et al. 2016
[43]
Wales 52.1˚N n = 2,927 MS
patients,
n = population
control
n.a n.a n.a X2 April
(Obs/Exp 1.21
95%CI 1.08–
1.36, p < .001)
n.s 5
Villar-Quiles
et al. 2016
[37]
Madrid 40.4˚N n = 1,335MS
patients,
n = population
control
439 896 43.4 ± 11.3 X2, Hewitt
and Roberson
n.s November
(OR 0.76;
p = 0.01),
January
(OR 0.744;
p = 0.007),
February
(OR 0.692;
p = 0.001)
6
Southern hemisphere
Becker et al.
(2013) [31]
Brazil (south, southeast,
and northeast regions)
14.2˚S n = 2,257 MS
patients,
n = population
control
625 1,632 42.1 ± 12.4 X2 October,
November,
December
(significant)
April, May,
June
(significant)
6
Fragoso
et al. 2013
[39]
South Amerika
(Argentina, Brazil, Chile
and Peru)
0–10˚S
11–20˚S
21–30˚S
31–40˚S
n = 1,207 MS
patients,
n = 1,207 controls
351 856 40.8 ± 12.6 Two-way
ANOVA and
X2
n.s 7
Southern and northern hemisphere
Verheul
et al. 2013
[44]
Argentina, Australia,
Belgium, Brazil, Canada,
Cuba, Denmark,
Germany, Israel, Italy,
Macedonia, Malta, Spain,
The Netherlands, Turkey
42˚7N N = 11,415 MS
patients
n = live-births
from national
registries
3,618 7,797 n.a X2 April
(Obs/
Exp = 1.091, X2
= 4.950,
p = 0.026)
June
(Obs/
Exp = 1.083, X2
= 4.210,
p = 0.040)
October
(Obs/
Exp = 0.919,
X2 = 4.515,
p = 0.034)
November
(Obs/
Exp = 0.918,
X2 = 4.368,
p = 0.037)
5
MS, multiple sclerosis; n.a, not available; RR, relative risk; CI, confidence interval; HR, hazard ratio; X2, chi-square test; n.s, not significant results; OR, odds ratio; Obs/
Exp, observed expected ratio.
https://doi.org/10.1371/journal.pone.0221645.t003
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analysis. In a first population-conservative analysis, they excluded duplicate populations and
retained studies with the highest case numbers, only. This analysis showed that particularly
November-born infants had a lower later occurrence of MS. In the second geographically con-
servative analysis, the effect of UV variation over the year was taken into consideration, and
more MS cases than expected were observed for subjects born in April, May and June, while
fewer diagnosis were made for subjects born in October and November. However, when anal-
ysis was performed only including studies of countries with a latitude of less than 52˚N, the
association between month of birth and later MS diagnosis disappeared with the exception of
a higher occurrence of MS among subjects born in June. At latitudes of greater than 52˚ there
is insufficient UV light for cutaneous vitamin D synthesis during half of the year (October
through March). Therefore, a latitude of 52˚ was chosen above which a significant month of
birth effect was expected while less variation was expected among populations living at lower
latitudes. Finally, a third overall-conservative analysis was performed with inclusion of all
studies. Here, the observed MS incidence was higher than expected for those born in April and
May, and lower for those born in October and November.
In the present review, we identified and included an additional fifteen studies that were not
included in the two previous reviews. Twelve of the fifteen studies were from the Northern
hemisphere, of which six reported results from European countries, one from U.S, four from
Asia, and one from Africa. Only two studies reported results from countries located in the
Southern hemisphere, while one included a worldwide cohort, Table 3.
The sample sizes of the seventeen studies ranged from 100 to 21,138. Seven of the studies
selected MS cases based on the McDonald or Poser criteria [31–37], four based on physician-
confirmed medical records [38–41], three based on ICD codes [42,43] and MS based registries
[44], while one was based on Association of British Neurologist criteria for use of drugs in MS
[45]. All studies except four, compared the birth dates of MS patients with that of the general
population, The four studies either did not have a comparison group or compared the birth
dates of MS patients with birth dates of non-neurological hospital patients, employees and
individuals accompanying patients [39,41,42,46]. The studies were also heterogeneous with
Table 4. The risk difference in developing MS between early and late age at migration.
First author, y (ref) Country of origin Country of migration Main findings Quality
The risk of MS is
"(increased)/
#(decreased) if
migration has been
in the period:
<15
years
>15
years
Migration from high to low risk area
Hammond et al. 2000
[52]
UK and Ireland Australia Reduced risk
independent of age
n.a
McLeod et al. 2011
[53]
UK and Ireland Australia # " n.a
Migration from low to high risk area
Cabre et al. 2005 [54] Martinique and
Guadeloupe
Returned back after immigrating
to France
" # 6
Berg-Hansen et. al
2015 [55]
Pakistan Norway 6
n.a, not available; This study [55] investigated effect of migration among the first and second generation of migrants
(for statistical values refer to the text).
https://doi.org/10.1371/journal.pone.0221645.t004
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respect to the statistical analyses. Some used Hewitt, Edwards’ or Cosinor tests while others
used Chi-square, and some studies even reported different results depending on which test
was used [33,36]. Nevertheless, a consistent seasonal tendency seemed apparent in almost all
studies with a generally increased number of MS births in late spring and a reduced one in late
autumn, except for four studies that did not demonstrate a significant relation between season
or the month of birth and later MS diagnosis [32,34,38,39].
Five studies reported results that were controlled for potential confounders such as place
and year of birth [32,38,39,45,47] and two of them indicated a significant month-of-birth asso-
ciation with later MS occurrence [45,47]. Two studies examined seasonality matched for year
and region of births [39,45] and one found significant month-of-birth association with later
MS diagnosis [45]. The difference in latitudinal gradient of the two studies may explain the
variation of their results with one being closer and the other farther from the earth equator.
In addition, one study compared births rates of MS patients with fathers (Fisher’s exact test,
p = 0.011), mothers (Fisher’s exact test, p = 0.004) or siblings of MS patients free from disease
(Fisher’s exact test, p = 0.011), and found a higher incidence among April born MS patients
compared to their relatives [33].
In this review, it was furthermore possible to pool the estimates of six studies from North-
ern hemisphere [43,47–50] in a meta-analysis. The analysis revealed 6% fewer than expected
MS cases in March (SIR 0.94, 95%CI, 0.89–1.0) and 12% more MS births than expected in
April (SIR 1.12, 95%CI, 1.06–1.18) with moderate heterogeneity in May, June, July and high
heterogeneity in November and December (for further details of meta-analysis results by
months (S1 Fig)).
The majority of included studies were of comparatively good quality, varying from five to
seven AMSTAR points (Tables A and B in S2 Table), while one study was of poor quality due
to its descriptive nature of the statistical analyses [40].
The latitudinal gradient of the examined countries ranged from 10˚S in the South to 62˚N
in the North. The limited number of studies from the Southern hemisphere did not allow iden-
tification of whether the month of birth patterns in MS differed according to different latitudi-
nal gradients. However, month-of-birth effects were apparent for the countries located at
higher latitudes [33,37,43,45] as opposed to the countries located at lower latitudes, and hence
being closer to the earth equator [34,39].
MS differences in early or late migrants and in the second generation of migrants. One
previous systematic review summarized results from migrant studies in relation to risk of MS
and differences seen according to time of migration (early and late in life migrants) and
among generations of migrants [51]. This review, rated of moderate quality (AMSTAR score
4), suggested that the risk of MS was largely dependent on influences occurring during the first
two decades of life, and that risk of MS seemed to change between generations of migrants,
although the authors of the review could not draw a firm conclusion due to obstacles in the
interpretation of migrant studies, and the limited number of high-quality studies [51].
The papers already included in this previous review were not included in the present
review, which identified four additional studies (Table 4). Three of them [52–54] reported
results for age at migration and risk of MS of which two examined migration from high to
low-risk area and one from low to a high-risk area. Only one study [55] addressed the question
whether the risk of MS development changed in the second generation of migrants as opposed
to the first generation. In the study among inhabitants of the French West Indies who returned
to Martinique and Guadeloupe after migrating to France, a significantly increased standard-
ized prevalence (SPR) and incidence ratio (SIR) for MS was found among West Indians who
migrated before the age of 15 as compared to migration at older age (SPR 5.99, 95% CI 3.79–
8.98 and SIR 4.05, 95% CI 2.17–6.83) [54]. In contrast, two later studies found no age
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dependence. The first of these studies found that immigrants from high-MS-risk areas, such as
Ireland and the United Kingdom, who migrated to low-MS-risk area Australia, reduced their
risk of developing MS independently of age at migration. Similarly, a case-control study that
was performed in order to avoid bias related to the long duration of residence in Australia, did
not find age related effects [52]. However, when McLeod et al. [53] later reanalyzed the same
materials, they reported, in contrast to previous findings, that the risk of developing MS
among immigrants from high to low-MS-risk zones was significantly lower among those who
migrated at an age younger than 15 years (risk ratio 22.3/100,000 vs 45.3/100,000). Finally, a
recent study from Norway compared the differences in MS prevalence between the first and
second generation of migrants. The study found that the SPR of MS increased sharply in the
second generation of migrants from Pakistan (SPR 1.62, 95% CI: 0.88–2.76) compared to the
first generation migrants (SPR 0.13, 95% CI: 0.05–0.28), indicates an approximately twelve-
fold increase in the risk of MS in the second generation of migrants [55].
The quality of the migrant studies could be assessed only for two of the four migration stud-
ies, both of which achieved a comparably good quality score but not higher because of their
cross-sectional nature [54,55] (Table B in S2 Table). For the two other studies methodological
quality could not be assessed as the methodology was insufficiently described [52,53].
Discussion
Overall, the findings of this review suggest that an association between early life vitamin D
availability and later risk of MS is possible, but also that there still is insufficient evidence to
firmly conclude that low vitamin D availability in early life increases the risk of MS in adult-
hood as no intervention and few cohort studies, only, have been published. Furthermore,
the results from the relatively few published observational studies were partly inconsistent,
with some demonstrating significant inverse association between circulating 25(OH)D
concentration in early life and risk of MS later in life, and some indicating no significant
association.
Two of the included case-cohort studies had relatively large sample sizes and both examined
dried blood spots collected from newborns for 25(OH)D for cases with MS onset and controls,
but still found conflicting results. Both studies were from Scandinavia, and while the Danish
study indicated a significant inverse association [26] the Swedish study found no association
[24]. Conflict in findings may be due to the difference in sample storage temperature, as dried
blood samples of the Swedish biobank were stored first at room temperature for six years and
then at 4˚C, while the Danish Newborn Screening biobank stored samples at -20˚C tempera-
ture. A lower storage temperature may reduce the risk of degradation and maintain higher
chemical stability of samples. The most comprehensive study to date in regards to control for
confounding was that by Ueda and colleagues [24] who attempted to combine several addi-
tional risk factors in early (month of birth, latitude of birth, breastfeeding) and adult life
(25-hydroxyvitamin D exposure, sun exposure, vitamin D intake from dairy products, fatty
fish consumption, smoking, body mass index at 20 years of age) including ancestry, MS hered-
ity and socioeconomic group. However, their results were essentially similar before and after
control for the additional confounders. It is likely that interaction between genetic and envi-
ronmental factors determine the risk of disease development, but exposure to Epstein-Barr
virus, smoking, and latitude/vitamin D found to be most appropriate as these factors have
shown the strongest evidence with MS development [56]. None of the studies adjusted for
these factors simultaneously.
In contrast to the results from the population studies, the result from the many seasonal
studies were relatively consistent, suggesting a lower occurrence of MS for late autumn born
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children on the Northern hemisphere. The overall excess of spring/summer MS births was fur-
ther confirmed in the meta-analysis from the selected Northern hemisphere studies adding
further support for a relation as meta-analyses allows greater precision in the effect size estima-
tion. However, publication bias is always a possibility since non-significant results are less
likely published [57], and publication bias may thus have resulted in an overestimation of the
positive results found in the present review. We wanted to assess the potential for publication
bias by inspection and testing asymmetry of funnel plots. However, although the visual inspec-
tion of the funnel plots suggested that there was no apparent tendency for publication bias
related to the studies in our meta-analyses, less than 10 studies were included, and the power
of the test was too low for distinguishing asymmetry. Therefore, it cannot be eliminated that
the results of the meta-analysis were subject to publication bias, and the interpretation there-
fore needs to be done with caution. The present results from the seasonal studies are in agree-
ment with previous systematic review findings by Torkildsen et al. [18] and Dobson et al. [30],
both of which concluding that those born in autumn or winter, and thus exposed during early
gestation to increased exposure to UV radiation, had a lower risk of later developing MS.
Fewer studies were conducted in the Southern hemisphere and did not consistently identify a
particular month or season of birth being of relevance for later MS development. Previous
studies have been criticized for potentially being false positive due to inadequate control for
confounders such as latitude and year of birth [58,59], adding caution to the interpretation of
the positive findings. Still, very few (5/15) of the included studies adjusted for confounding
from factors such as latitude and year of birth, and two studies, even indicated a significant
month of birth effect after adjustment [45,47]. It is therefore still not clear if accounting for
these sources of bias removes month of birth effect on MS development. Furthermore, the
use of the average latitude as a proxy for the exposure of the population to UV radiation, and
therefore for vitamin D formation, may be too imprecise. Many countries cover a wide range
of latitudes amongst which the UV radiation may vary. Moreover, altitude above sea level of
the place of residence of the subjects included in the studies, which is also a decisive factor of
UV exposure, is not taken into consideration. Factors such as differences in temperature, sun-
screen use along with clothing, which also may happen for e.g. religious reasons, might influ-
ence the seasonality effect on MS development. Also, potential explanations for seasonal risk
variations could be seasonal differences to vitamin D exposure and differential responses of
the body to sunlight exposure, which could affect the immune system during a vulnerable
time of development. Other biological mechanisms for a month of birth effect have been
described. For instance, a study examined blood samples from umbilical cords and found that
those born in May had both lower levels of vitamin D and higher levels of autoreactive T-cells
as opposed to those born in November [60]. Thus, high levels of autoreactive T-cells that attack
the immune system and may trigger autoimmune disease, could also serve as a biological
explanation for the month of birth relations with later MS. However, this needs further investi-
gation. It is also possible that UVB is independently associated with risk of MS [61]. In addi-
tion, as MS is primarily considered to be an autoimmune disease, any season-dependent
variation in regional patterns of contagious diseases may interfere with the development of
autoreactive leukocytes triggering MS. Whether, in this regard, maternal infections during
pregnancy may increase the risk of MS onset in the offspring remains to be clarified in future
studies. One previous study examined this and did not see a significant association between
infections during pregnancy and risk of MS development, possibly due to lack of power [38].
However, if such relation exists, the higher general risk of infection during winter (in January-
March in the Western world where most studies were derived) may also provide reason why
month of birth could influence MS incidence in the offspring. Another factor triggering the
activity of autoreactive leukocytes responsible for MS onset are low levels of melatonin, which
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are lowest during spring [62]. Increased plasma levels of melatonin correlate with MS relapses
[63]. Whether or not low levels of maternal melatonin during spring contributed to the ele-
vated risk of MS onset in the offspring remains to be clarified in future studies. Finally, use
of different statistical modeling may have led to differing results. Non-parametric tests such
as Hewitt, Edwards’ and Cosinor tests may be more suitable in assessing seasonal patterns,
whereas the Chi-square test may be less sensitive especially in case of a small sample size
[36,64]. However, it is important to highlight that even though seasonal correlation analyses
provide support for a link between MS onset and early life sun exposure, they do not provide
evidence for an association between vitamin D and MS, as other seasonal factors such as infec-
tion, maternal nutrition, gene expression and other climatic factors also vary with season and
may influence the risk of MS [64].
Finally, several of the migration studies also provided reasonably consistent results suggest-
ing a difference in MS risk due to migration and between generations. However, even if, preva-
lence of a disease is a good epidemiological tool when measuring burden of disease, it is not
necessarily the best tool for assessing the risk of disease due to migration. Also, as it was men-
tioned in a previous review [51], migrant studies may be subject to a quite high risk of selection
bias, as migrants rarely are appropriate representatives of the population of the country of ori-
gin, as they usually differ by age, health and socioeconomic status.
While the comprehensive coverage of this systematic review is considered a strength, some
limitations should also be mentioned. First, five of six population studies related to early life
vitamin D and risk of MS in adulthood were from the Nordic countries and therefore the gen-
eralization to other populations of different ethnic backgrounds and locations might not be
possible.
Conclusion
Despite a growing interest in the relationship between vitamin D availability in early life and
risk of MS in adulthood, the evidence from current studies remains suggestive. Nevertheless,
this systematic review gives further support for an association between measured low 25(OH)
D availability in early life and the later onset of MS. The findings from the season of birth, lati-
tude and migration studies that are considered as proxy measures for vitamin D availability,
provide some support for a possible association between low vitamin D in early life and later
risk of MS, but the results from the population based studies are still relatively few and not
entirely consistent, and intervention studies in the field are still absent. Overall, further
research is therefore needed.
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